Tragara Pharmaceuticals Garners $5,000,000 Series B Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9158ccd0-b246-44e4-b6b9-ad59e2c33c06&Preview=1 -
Date
2/8/2010 -
Company Name
Tragara Pharmaceuticals -
Mailing Address
10955 Vista Sorrento Parkway San Diego, CA 92130 -
Company Description
Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of cancer and inflammation-related diseases. Tragara launched operations in January 2007 and is focusing its development resources on two programs: (1) TP1001 for the treatment of inflammation related disorders and (2) TP2001 for the treatment of solid tumors. -
Website
http://www.tragarapharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$5,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Domain Associates -
Venture Investor
Mitsubishi Corporation -
Venture Investor
Morgenthaler Ventures -
Venture Investor
Oxford Bioscience Partners -
Venture Investor
ProQuest Investments
